112 related articles for article (PubMed ID: 7463157)
1. Effect of coronary blood flow and site of injection on Tc-99m PPi detection of early canine myocardial infarcts.
Parkey RW; Kulkarni PV; Lewis SE; Datz FL; Dehmer GJ; Gutekunst DP; Buja LM; Bonte FJ; Willerson JT
J Nucl Med; 1981 Feb; 22(2):133-7. PubMed ID: 7463157
[TBL] [Abstract][Full Text] [Related]
2. Quantification of myocardial injury produced by temporary coronary artery occlusion and reflow with technetium-99m-pyrophosphate.
Jansen DE; Corbett JR; Buja LM; Hansen C; Ugolini V; Parkey RW; Willerson JT
Circulation; 1987 Mar; 75(3):611-7. PubMed ID: 3493088
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m(Sn2+)pyrophosphate in ischemic and infarcted dog myocardium in early stages of acute coronary occlusion: histochemical and tissue-counting comparisons.
Bianco JA; Kemper AJ; Taylor A; Lazewatsky J; Tow DE; Khuri SF
J Nucl Med; 1983 Jun; 24(6):485-91. PubMed ID: 6854398
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of coronary reperfusion for acute myocardial infarction by emission CT using technetium-99m pyrophosphate].
Hashimoto T; Kambara H; Nohara R; Fudo T; Uozu K; Tamaki S; Kawai C
J Cardiol; 1987 Jun; 17(2):231-9. PubMed ID: 2966242
[TBL] [Abstract][Full Text] [Related]
5. Modified technetium-99m heparin for the imaging of acute experimental myocardial infarcts.
Kulkarni PV; Parkey RW; Wilson JE; Lewis SE; Buja LM; Bonte FJ; Willerson JT
J Nucl Med; 1980 Feb; 21(2):117-21. PubMed ID: 7356749
[TBL] [Abstract][Full Text] [Related]
6. Early positive technetium-99m stannous pyrophosphate images as a marker of reperfusion after thrombolytic therapy for acute myocardial infarction.
Wheelan K; Wolfe C; Corbett J; Rude RE; Winniford M; Parkey RW; Buja LM; Willerson JT
Am J Cardiol; 1985 Aug; 56(4):252-6. PubMed ID: 4025161
[TBL] [Abstract][Full Text] [Related]
7. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.
Buja LM; Tofe AJ; Kulkarni PV; Mukherjee A; Parkey RW; Francis MD; Bonte FJ; Willerson JT
J Clin Invest; 1977 Sep; 60(3):724-40. PubMed ID: 893676
[TBL] [Abstract][Full Text] [Related]
8. A comparison of infarct identification with technetium-99m pyrophosphate and staining with triphenyl tetrazolium chloride.
Izquierdo C; Devous MD; Nicod P; Buja LM; Parkey RW; Bonte FJ; Willerson JT; Lewis SE
J Nucl Med; 1983 Jun; 24(6):492-7. PubMed ID: 6304264
[TBL] [Abstract][Full Text] [Related]
9. Sequential myocardial scintigraphy with technetium-99m stannous pyrophosphate following myocardial infarction.
Malin FR; Rollo FD; Gertz EW
J Nucl Med; 1978 Oct; 19(10):1111-5. PubMed ID: 722321
[TBL] [Abstract][Full Text] [Related]
10. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous display of gated technetium-99m stannous pyrophosphate and gated blood-pool scintigrams.
Corbett JR; Lewis SE; Dehmer G; Bonte FJ; Parkey RW; Buja LM; Willerson JT
J Nucl Med; 1981 Aug; 22(8):671-7. PubMed ID: 7264755
[TBL] [Abstract][Full Text] [Related]
12. A computer-based scintigraphic method for sizing acute inferior myocardial infarcts.
Lewis MH; Buja LM; Parkey RW; Mishelevich DJ; Bonte FJ; Saffer SI; Richmond JR; Willerson JT
Radiology; 1980 Aug; 136(2):439-42. PubMed ID: 7403522
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
14. Imaging of experimental myocardial infarction with technetium-99m 2,3-dimercaptosuccinic acid.
Karlsberg RP; Milne N; Lyons KP; Aronow WS
J Nucl Med; 1981 Mar; 22(3):253-7. PubMed ID: 6259303
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m stannous pyrophosphate "hot spot" imaging to detect acute myocardial infarcts.
Willerson JT; Parkey RW; Buja LM; Bonte FJ
Cardiovasc Clin; 1979; 10(2):139-48. PubMed ID: 487370
[No Abstract] [Full Text] [Related]
16. Relationship between Tl-201, Tc-99m (Sn) pyrophosphate and F-18 2-deoxyglucose uptake in ischemically injured dog myocardium.
Sochor H; Schwaiger M; Schelbert HR; Huang SC; Ellison D; Hansen H; Selin C; Parodi O; Phelps ME
Am Heart J; 1987 Nov; 114(5):1066-77. PubMed ID: 3673874
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphy.
Willerson JT; Parkey RW; Bonte FJ; Lewis SE; Corbett J; Buja LM
Semin Nucl Med; 1980 Jan; 10(1):54-69. PubMed ID: 6246640
[TBL] [Abstract][Full Text] [Related]
18. Morphologic correlates of technetium-99m stannous pyrophosphate imaging of acute myocardial infarcts in dogs.
Buja LM; Parkey RW; Dees JH; Stokely EM; Harris RA; Bonte FJ; Willerson JT
Circulation; 1975 Oct; 52(4):596-607. PubMed ID: 168990
[TBL] [Abstract][Full Text] [Related]
19. Technetium-labeled heparin: preliminary report of a new radiopharmaceutical with potential for imaging damaged coronary arteries and myocardium.
Kulkarni PV; Parkey RW; Buja LM; Wilson JE; Bonte FJ; Willerson JT
J Nucl Med; 1978 Jul; 19(7):810-5. PubMed ID: 660285
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m MIBI to assess coronary collateral flow during acute myocardial infarction in two closed-chest animal models.
Christian TF; O'Connor MK; Schwartz RS; Gibbons RJ; Ritman EL
J Nucl Med; 1997 Dec; 38(12):1840-6. PubMed ID: 9430456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
